Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





ETHYLENE CHLOROHYDRIN								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 107-07-3; **Chemical Formula:** ClCH2CH2OH
OSHA formerly had an 8-hour TWA limit of 5 ppm, with a skin notation, for ethylene chlorohydrin. The ACGIH has a ceiling limit of 1 ppm, also with a skin notation. The proposed PEL was a ceiling of 1 ppm, with a skin notation. NIOSH (Ex. 8-47) concurred with the proposed limit, and the final rule establishes this limit and retains the skin notation. Ethylene chlorohydrin is a colorless liquid with a faint, ethereal odor.
A broad range of serious health hazards are associated with exposure to this substance; these include central nervous system effects, cardiovascular effects, liver damage, kidney damage, gastrointestinal effects, skin irritation, eye irritation, and mutagenic effects. OSHA considers that all of these effects constitute material health impairments. The oral LD(50) for rats is 72 mg/kg, and the intraperitoneal LD(50) in the same species is 56 mg/kg (Goldblatt and Chiesman 1944/Ex. 1-980). In guinea pigs, the intraperitoneal LD(50) is 98 mg/kg, and the percutaneous LD(50) is 205 mg/kg (Wahlberg and Boman 1978/Ex. 1-938).
The skin absorption rate for ethylene chlorohydrin is high; Semenova and associates (1978/Ex. 1-932) determined that the LD(50) must be reduced to one-fifth of its original value if ethylene chlorohydrin is administered daily for 20 days (Semenova, Kazanina, Fedyanina et al. 1978/Ex. 1-932).
The inhalation toxicity of ethylene chlorohydrin is also high. Ambrose (1950/Ex. 1-888) reported that a single one-hour exposure at 7.5 ppm and repeated one-hour exposures at 2 ppm can be fatal to rats. Exposures of 15 minutes daily at concentrations of from 900 to 1000 ppm were fatal to rats within a few days (Goldblatt and Chiesman 1944/Ex. 1-980).
In subacute and chronic studies, rats have died from a daily dietary dose of 67.5 mg/kg (Oser, Morgareidge, Cox, and Carson 1975/Ex. 1-923). Semenova and associates (1980, as cited in ACGIH 1986/Ex. 1-3, p. 248) reported a four-month no-effect inhalation level of 0.0033 ppm; at 0.017 ppm, slight CNS changes and alterations in the urinary secretion of nitrogen were observed after four months. These investigators also observed increased chromosomal aberrations in bone marrow in rats exposed at the 0.22-ppm level for four months (Semenova, Kazanina, Fedyanina et al. 1980, as cited in ACGIH 1986/Ex. 1-3, p. 248).
Voogt and Vet (1969/Ex. 1-1205) tested ethylene chlorohydrin in Klebsiella pneumoniae and found it strongly mutagenic. This finding was confirmed by the Ames test in Salmonella typhimurium ; ethylene chlorohydrin reacts with DNA, since it inhibits the growth of DNA-deficient bacteria (Rosenkranz and Wlodkowski 1974/Ex. 1-1201). A dose-related increase of liver protein and depletion in glutathion was observed in rats after a single dose of ethylene chlorohydrin of from 10 to 50 mg/kg (Friedman, Scalera, Balazs et al. 1977/Ex. 1-1198).
One fatal and several nonfatal cases of poisoning in industrial workers have been reported from exposure (for unspecified periods of time) to ethylene chlorohydrin at levels of between 300 and 500 ppm. An autopsy of the worker who died revealed severe damage to the liver and brain, as well as effects in other organs. The survivors experienced nausea, vomiting, and irritation of the eyes, nose, and lungs (Bush, Abrams, and Brown 1949/Ex. 1-1196). Dierker and Brown (1944/Ex. 1-1197) reported that a two-hour inhalation exposure to 300 ppm was fatal in one accidental exposure. OSHA received no comments, other than that of NIOSH (Ex. 8-47), on this substance.
In the final rule, OSHA is establishing a ceiling limit of 1 ppm for ethylene chlorohydrin and is retaining the skin notation. The Agency concludes that this limit will substantially reduce the significant risk of central nervous system and other systemic effects associated with workplace exposures at the levels permitted by the TWA limit alone. The skin notation is retained because ethylene chlorohydrin is readily absorbed through the skin.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue